Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
San Francisco, CA and Covington, KY, August 4, 2020 — Angion Biomedica Corp. (Angion), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 4, 2020 Category: Pharmaceuticals Source Type: clinical trials

Online Learning Portal on Under Five Pneumonia
Conditions:   Pneumonia;   Childhood Pneumonia;   Infectious Disease;   Acute Respiratory Infection Intervention:   Other: E-learning portal Sponsors:   University of Edinburgh;   Maternal, Neonatal and Child Health Research Network Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2020 Category: Research Source Type: clinical trials

Extracellular Vesicle Infusion Therapy for Severe COVID-19
Conditions:   Covid19;   ARDS;   Pneumonia, Viral Intervention:   Biological: DB-001 Sponsor:   Direct Biologics, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

mHealth for Pneumonia Prevention
Conditions:   Pneumonia;   Childhood Pneumonia;   Infectious Disease;   Acute Respiratory Infection Intervention:   Behavioral: Mobile health (mHealth) for pneumonia Sponsors:   University of Edinburgh;   Maternal, Neonatal and Child Health Research Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebo Sponsors:   Kristin Hudock;   Kiniksa Pharmaceuticals, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Extracellular Vesicle Infusion Therapy for Severe COVID-19
Conditions:   Covid19;   ARDS;   Pneumonia, Viral Intervention:   Biological: DB-001 Sponsor:   Direct Biologics, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

mHealth for Pneumonia Prevention
Conditions:   Pneumonia;   Childhood Pneumonia;   Infectious Disease;   Acute Respiratory Infection Intervention:   Behavioral: Mobile health (mHealth) for pneumonia Sponsors:   University of Edinburgh;   Maternal, Neonatal and Child Health Research Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebo Sponsors:   Kristin Hudock;   Kiniksa Pharmaceuticals, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Extracellular Vesicle Infusion Therapy for Severe COVID-19
Conditions:   Covid19;   ARDS;   Pneumonia, Viral Intervention:   Biological: DB-001 Sponsor:   Direct Biologics, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

mHealth for Pneumonia Prevention
Conditions:   Pneumonia;   Childhood Pneumonia;   Infectious Disease;   Acute Respiratory Infection Intervention:   Behavioral: Mobile health (mHealth) for pneumonia Sponsors:   University of Edinburgh;   Maternal, Neonatal and Child Health Research Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebo Sponsors:   Kristin Hudock;   Kiniksa Pharmaceuticals, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Extracellular Vesicle Infusion Therapy for Severe COVID-19
Conditions:   Covid19;   ARDS;   Pneumonia, Viral Intervention:   Biological: DB-001 Sponsor:   Direct Biologics, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

mHealth for Pneumonia Prevention
Conditions:   Pneumonia;   Childhood Pneumonia;   Infectious Disease;   Acute Respiratory Infection Intervention:   Behavioral: Mobile health (mHealth) for pneumonia Sponsors:   University of Edinburgh;   Maternal, Neonatal and Child Health Research Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebo Sponsors:   Kristin Hudock;   Kiniksa Pharmaceuticals, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Extracellular Vesicle Infusion Therapy for Severe COVID-19
Conditions:   Covid19;   ARDS;   Pneumonia, Viral Intervention:   Biological: DB-001 Sponsor:   Direct Biologics, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

mHealth for Pneumonia Prevention
Conditions:   Pneumonia;   Childhood Pneumonia;   Infectious Disease;   Acute Respiratory Infection Intervention:   Behavioral: Mobile health (mHealth) for pneumonia Sponsors:   University of Edinburgh;   Maternal, Neonatal and Child Health Research Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebo Sponsors:   Kristin Hudock;   Kiniksa Pharmaceuticals, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Extracellular Vesicle Infusion Therapy for Severe COVID-19
Conditions:   Covid19;   ARDS;   Pneumonia, Viral Intervention:   Biological: DB-001 Sponsor:   Direct Biologics, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

mHealth for Pneumonia Prevention
Conditions:   Pneumonia;   Childhood Pneumonia;   Infectious Disease;   Acute Respiratory Infection Intervention:   Behavioral: Mobile health (mHealth) for pneumonia Sponsors:   University of Edinburgh;   Maternal, Neonatal and Child Health Research Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebo Sponsors:   Kristin Hudock;   Kiniksa Pharmaceuticals, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients
Conditions:   Covid19;   SARS-CoV-2 Infection;   Pneumonia;   Copd;   CKD;   Cardiac Event;   Overweight and Obesity;   Cardiovascular Diseases;   Diabetes;   Hypertension;   Coronary Heart Disease Intervention:   Other: non-interventional Sponsor:   Eurasian Association of Therapists Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Extracellular Vesicle Infusion Therapy for Severe COVID-19
Conditions:   Covid19;   ARDS;   Pneumonia, Viral Intervention:   Biological: DB-001 Sponsor:   Direct Biologics, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

mHealth for Pneumonia Prevention
Conditions:   Pneumonia;   Childhood Pneumonia;   Infectious Disease;   Acute Respiratory Infection Intervention:   Behavioral: Mobile health (mHealth) for pneumonia Sponsors:   University of Edinburgh;   Maternal, Neonatal and Child Health Research Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation
Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebo Sponsors:   Kristin Hudock;   Kiniksa Pharmaceuticals, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients
Conditions:   Covid19;   SARS-CoV-2 Infection;   Pneumonia;   Copd;   CKD;   Cardiac Event;   Overweight and Obesity;   Cardiovascular Diseases;   Diabetes;   Hypertension;   Coronary Heart Disease Intervention:   Other: non-interventional Sponsor:   Eurasian Association of Therapists Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials

EVALUATION OF SAFETY AND EFFICIENCY OF METHOD OF EXOSOME INHALATION IN SARS-CoV-2 ASSOCIATED PNEUMONIA.
Conditions:   Covid19;   SARS-CoV-2 PNEUMONIA;   COVID-19 Interventions:   Procedure: EXO 1 inhalation;   Procedure: EXO 2 inhalation;   Procedure: Placebo inhalation Sponsors:   State-Financed Health Facility " Samara Regional Medical Center Dinasty " ;   Clinics of the Federal State Budgetary Educational Institution SSMU;   Samara Regional Clinical Hospital V.D. Seredavin Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2020 Category: Research Source Type: clinical trials

Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.
Conditions:   Covid19;   SARS-CoV-2 PNEUMONIA;   COVID-19 Interventions:   Procedure: EXO 1 inhalation;   Procedure: EXO 2 inhalation;   Procedure: Placebo inhalation Sponsors:   State-Financed Health Facility " Samara Regional Medical Center Dinasty " ;   Clinics of the Federal State Budgetary Educational Institution SSMU;   Samara Regional Clinical Hospital V.D. Seredavin Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2020 Category: Research Source Type: clinical trials

EVALUATION OF SAFETY AND EFFICIENCY OF METHOD OF EXOSOME INHALATION IN SARS-CoV-2 ASSOCIATED PNEUMONIA.
Conditions:   Covid19;   SARS-CoV-2 PNEUMONIA;   COVID-19 Interventions:   Procedure: EXO 1 inhalation;   Procedure: EXO 2 inhalation;   Procedure: Placebo inhalation Sponsors:   State-Financed Health Facility " Samara Regional Medical Center Dinasty " ;   Clinics of the Federal State Budgetary Educational Institution SSMU;   Samara Regional Clinical Hospital V.D. Seredavin Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2020 Category: Research Source Type: clinical trials

Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
Conditions:   Covid19;   Ventilator Associated Pneumonia;   Nosocomial Pneumonia Intervention:   Sponsors:   Groupe Hospitalier Paris Saint Joseph;   Centre Hospitalier Victor Dupouy Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2020 Category: Research Source Type: clinical trials

N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia
Condition:   COVID19 Pneumonia Intervention:   Other: Pro BNP , Vitamin D Sponsors:   Cairo University;   Kasr El Aini Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2020 Category: Research Source Type: clinical trials

Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection
Condition:   COVID-19 Interventions:   Drug: Duvelisib;   Drug: Placebo Sponsors:   Emory University;   Verastem, Inc.;   University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2020 Category: Research Source Type: clinical trials

Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
Condition:   COVID-19 Interventions:   Drug: Duvelisib;   Drug: Placebo Sponsors:   Emory University;   Verastem, Inc.;   University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2020 Category: Research Source Type: clinical trials